These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8016577)

  • 21. Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study.
    Alizadeh-Naeeni M; Saberi-Firoozi M; Pourkhajeh A; Taheri H; Malekzadeh R; Derakhshan MH; Massarrat S;
    Digestion; 2002; 66(2):92-8. PubMed ID: 12428068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia.
    Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I
    Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
    Vakil N; Talley NJ; Stolte M; Sundin M; Junghard O; Bolling-Sternevald E
    Aliment Pharmacol Ther; 2006 Jul; 24(1):55-63. PubMed ID: 16803603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia.
    Schütze K; Hentschel E; Hirschl AM
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):41-6. PubMed ID: 8900907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):177-85. PubMed ID: 8287340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal motility in patients with non-ulcer dyspepsia: a role for Helicobacter pylori infection?
    Pieramico O; Ditschuneit H; Malfertheiner P
    Am J Gastroenterol; 1993 Mar; 88(3):364-8. PubMed ID: 8438842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonulcer dyspepsia: what it is and what it is not.
    Locke GR
    Mayo Clin Proc; 1999 Oct; 74(10):1011-4; quiz 1015. PubMed ID: 10918866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dyspepsia: current understanding and management.
    Agréus L; Talley NJ
    Annu Rev Med; 1998; 49():475-93. PubMed ID: 9509276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-ulcer dyspepsia: myths and realities.
    Talley NJ
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():145-62. PubMed ID: 1888833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
    Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Should Helicobacter pylori infection be considered in the management of dyspeptic patients?].
    De Korwin JD
    Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C79-94. PubMed ID: 10880917
    [No Abstract]   [Full Text] [Related]  

  • 33. Functional dyspepsia. Symptoms and underlying mechanism.
    Camilleri M; Thompson DG; Malagelada JR
    J Clin Gastroenterol; 1986 Aug; 8(4):424-9. PubMed ID: 3531316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Functional dyspepsia. Old wine in new bottles?].
    Kreiss C; Fried M
    Schweiz Med Wochenschr; 1994 Mar; 124(10):391-401. PubMed ID: 8153599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia.
    Bruley Des Varannes S; Fléjou JF; Colin R; Zaïm M; Meunier A; Bidaut-Mazel C
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1177-85. PubMed ID: 11472320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dyspepsia: organic versus functional.
    Oustamanolakis P; Tack J
    J Clin Gastroenterol; 2012 Mar; 46(3):175-90. PubMed ID: 22327302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In dyspeptic patients without gastric phase III of the migrating motor complex, Helicobacter pylori eradication produces no short-term changes in interdigestive motility pattern.
    Testoni PA; Bagnolo F
    Scand J Gastroenterol; 2000 Aug; 35(8):808-13. PubMed ID: 10994618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranitidine in the treatment of non-ulcer dyspepsia. A placebo-controlled study in the Federal Republic of Germany.
    Müller P; Hotz J; Franz E; Simon B
    Arzneimittelforschung; 1994 Oct; 44(10):1130-2. PubMed ID: 7818586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duodenal ulcer, Helicobacter pylori, and gastric secretion.
    Chandrakumaran K; Vaira D; Hobsley M
    Gut; 1994 Aug; 35(8):1033-6. PubMed ID: 7926901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.